Karl Münger
Impact in
- Epidemiology top 0.02%
- Cervical Cancer and HPV Research
- Hepatitis B Virus Studies
- Oncology top 0.05%
- Cancer-related Molecular Pathways
- Viral-associated cancers and disorders
Papers in
- Epidemiology 96
- Cervical Cancer and HPV Research 91
- Hepatitis B Virus Studies 10
- Oncology 93
- Cancer-related Molecular Pathways 77
- Viral-associated cancers and disorders 14
- Co-authors
- Peter M. Howley (30 shared papers)Nicholas J. Dyson (3 shared papers)Stefan Duensing (21 shared papers)William C. Phelps (10 shared papers)Margaret E. McLaughlin-Drubin (15 shared papers)Ed Harlow (4 shared papers)D. Leanne Jones (9 shared papers)Martin Scheffner (6 shared papers)
- Journals
- Journal of Virology (26 papers)Proceedings of the National Academy of Sciences (19 papers)Virology (19 papers)Oncogene (11 papers)mBio (7 papers)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Karl Münger
187 papers receiving 22.5k citations
Karl Münger's Hit Papers
Peers
Comparison fields: 5 of 147
- Epidemiology 10.8k
- Oncology 8.7k
- Otorhinolaryngology 1.1k
- Cancer Research 2.9k
- Immunology 3.4k
Countries citing papers authored by Karl Münger
This map shows the geographic impact of Karl Münger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Münger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Münger more than expected).
Fields of papers citing papers by Karl Münger
This network shows the impact of papers produced by Karl Münger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Münger. The network helps show where Karl Münger may publish in the future.
Co-authors
The 25 scholars most cited alongside Karl Münger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 190 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Human Papilloma Virus-16 E7 Oncoprotein Is Able to Bind to the Retinoblastoma Gene Product Hit paper breakdown → | 1989 | 2483 |
| 2 | The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes Hit paper breakdown → | 1989 | 1125 |
| 3 | Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. Hit paper breakdown → | 1989 | 971 |
| 4 | Mechanisms of Human Papillomavirus-Induced Oncogenesis Hit paper breakdown → | 2004 | 773 |
| 5 | The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Hit paper breakdown → | 1991 | 736 |
| 6 | Human papillomavirus immortalization and transformation functions Hit paper breakdown → | 2002 | 586 |
| 7 | The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A Hit paper breakdown → | 1988 | 580 |
| 8 | TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains Hit paper breakdown → | 1990 | 545 |
| 9 | Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Hit paper breakdown → | 1992 | 502 |
| 10 | Human Viral Oncogenesis: A Cancer Hallmarks Analysis Hit paper breakdown → | 2014 | 478 |
| 11 | 2001 | 468 | |
| 12 | 2000 | 377 | |
| 13 | 1997 | 367 | |
| 14 | 2001 | 360 | |
| 15 | The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. | 2002 | 318 |
| 16 | 1992 | 317 | |
| 17 | 2013 | 314 | |
| 18 | 2008 | 314 | |
| 19 | 2012 | 299 | |
| 20 | 2007 | 280 |
About Karl Münger
Karl Münger is a scholar working on Epidemiology, Oncology, Molecular Biology, Genetics and Cancer Research, having authored 190 papers that have together received 23.1k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (91 papers), Cancer-related Molecular Pathways (77 papers), Virus-based gene therapy research (42 papers), Molecular Biology Techniques and Applications (16 papers), Ubiquitin and proteasome pathways (14 papers), Microtubule and mitosis dynamics (14 papers), Viral-associated cancers and disorders (14 papers) and Hepatitis B Virus Studies (10 papers). The work is most often cited by research in Epidemiology (10.8k citations), Oncology (8.7k citations), Otorhinolaryngology (1.1k citations), Cancer Research (2.9k citations) and Immunology (3.4k citations). Karl Münger has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Peter M. Howley, Nicholas J. Dyson, Stefan Duensing, William C. Phelps, Margaret E. McLaughlin-Drubin, Ed Harlow, D. Leanne Jones, Martin Scheffner, Richard Schlegel and Carole Yee. Their work appears in journals such as Journal of Virology, Proceedings of the National Academy of Sciences, Virology, Oncogene and mBio.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.